Charles Peterfy
Impact in
- Rheumatology top 0.01%
- Rheumatoid Arthritis Research and Therapies
- Osteoarthritis Treatment and Mechanisms
- Musculoskeletal synovial abnormalities and treatments
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Orthopedics and Sports Medicine top 0.5%
- Bone and Joint Diseases
Papers in
- Rheumatology 142
- Rheumatoid Arthritis Research and Therapies 97
- Osteoarthritis Treatment and Mechanisms 39
- Musculoskeletal synovial abnormalities and treatments 30
- Systemic Lupus Erythematosus Research 16
- Spondyloarthritis Studies and Treatments 13
- Surgery 24
- Total Knee Arthroplasty Outcomes 7
- Co-authors
- Harry K. Genant (50 shared papers)Philip G. Conaghan (49 shared papers)Paul Emery (28 shared papers)Ali Guermazi (14 shared papers)Michael C. Nevitt (5 shared papers)Philip O’Connor (14 shared papers)Erika Schneider (1 shared paper)P F Tirman (5 shared papers)
- Journals
- Annals of the Rheumatic Diseases (36 papers)The Journal of Rheumatology (21 papers)Osteoarthritis and Cartilage (16 papers)Lara D. Veeken (5 papers)Seminars in Arthritis and Rheumatism (5 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Charles Peterfy
173 papers receiving 12.6k citations
Charles Peterfy's Hit Papers
Peers
Comparison fields: 5 of 148
- Rheumatology 8.9k
- Orthopedics and Sports Medicine 1.0k
- Hematology 1.0k
- Surgery 2.1k
- Genetics 408
Countries citing papers authored by Charles Peterfy
This map shows the geographic impact of Charles Peterfy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Peterfy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Peterfy more than expected).
Fields of papers citing papers by Charles Peterfy
This network shows the impact of papers produced by Charles Peterfy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Peterfy. The network helps show where Charles Peterfy may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles Peterfy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 174 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Whole-Organ Magnetic Resonance Imaging Score (WORMS) of the knee in osteoarthritis Hit paper breakdown → | 2003 | 1238 |
| 2 | OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. Hit paper breakdown → | 2003 | 604 |
| 3 | An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis Hit paper breakdown → | 2008 | 598 |
| 4 | The osteoarthritis initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee Hit paper breakdown → | 2008 | 564 |
| 5 | Presence of significant synovitis in rheumatoid arthritis patients with disease‐modifying antirheumatic drug–induced clinical remission: Evidence from an imaging study may explain structural progression Hit paper breakdown → | 2006 | 538 |
| 6 | Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve‐month, multicenter, randomized, double‐blind, placebo‐controlled, phase II clinical trial Hit paper breakdown → | 2008 | 439 |
| 7 | Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase Hit paper breakdown → | 2019 | 334 |
| 8 | 2006 | 328 | |
| 9 | 2006 | 316 | |
| 10 | 1999 | 296 | |
| 11 | 2009 | 263 | |
| 12 | 2010 | 231 | |
| 13 | 2006 | 203 | |
| 14 | 2004 | 200 | |
| 15 | 2009 | 194 | |
| 16 | 2004 | 174 | |
| 17 | 2008 | 174 | |
| 18 | 2010 | 169 | |
| 19 | 1998 | 156 | |
| 20 | 2009 | 149 |
About Charles Peterfy
Charles Peterfy is a scholar working on Rheumatology, Surgery, Orthopedics and Sports Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 174 papers that have together received 12.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (97 papers), Osteoarthritis Treatment and Mechanisms (39 papers), Musculoskeletal synovial abnormalities and treatments (30 papers), Bone and Joint Diseases (18 papers), Systemic Lupus Erythematosus Research (16 papers), Spondyloarthritis Studies and Treatments (13 papers), Sarcoma Diagnosis and Treatment (7 papers) and Total Knee Arthroplasty Outcomes (7 papers). The work is most often cited by research in Rheumatology (8.9k citations), Orthopedics and Sports Medicine (1.0k citations), Hematology (1.0k citations), Surgery (2.1k citations) and Genetics (408 citations). Charles Peterfy has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Harry K. Genant, Philip G. Conaghan, Paul Emery, Ali Guermazi, Michael C. Nevitt, Philip O’Connor, Erika Schneider, P F Tirman, Mikkel Østergaard and S. Zaïm. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology, Osteoarthritis and Cartilage, Lara D. Veeken and Seminars in Arthritis and Rheumatism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.